1 completed, 1 recruiting. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Brava: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nivolumab-ipilimumab and Chemoradiation for Cervical Cancer Nivolumab 40 mg in 4 ml Injection, Ipilimumab 200 MG in 40 ML Injection, Chemoradiation - Uterine Cervical Neoplasms | Phase 2 | Recruiting | Hospital Israelita Albert Einstein | 112 | 2022-08-30 | 2024-01-05 |
| Breast Reconstruction and Augmentation With Brava Enhanced Autologous Fat Micro Grafting Brava Autologous Fat Transfer System - Mammaplasty, Mastectomy | Not applicable | Completed | Brava | 589 | 2010-01-01 | 2015-05-05 |
Uterine Cervical Neoplasms (1)
Chemoradiotherapy (1) · Injections (1) · Ipilimumab (1) · Nivolumab (1)
Brazil (1) · United States (1)
Fernando Maluf, MD (1) · Roger K Khouri, MD (1)